Form 4: Amgen EVP Esteban Santos Reports Changes in Beneficial Ownership

EVP Esteban Santos reports acquisition of Amgen stock through restricted stock units, dividend equivalents, and a 401(k) plan.

Summary

• Esteban Santos, EVP of Operations at Amgen, filed a Form 4 detailing changes in beneficial ownership of Amgen stock.
• On March 6, 2024, Santos acquired 12,278 shares of common stock.
• These shares were acquired through restricted stock units (RSUs), dividend equivalents (DEs), and the company's 401(k) plan.
• Santos directly owns 76,125 shares of Amgen common stock following the reported transactions.
• Santos also indirectly owns 849.5648 shares through the 401(k) plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing showing an executive acquiring shares through compensation, which is generally a positive sign of alignment with shareholder interests, but not a major market-moving event.

Positives

• The acquisition of shares by an executive could be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the RSUs extend to 2027.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive ownership.

Key Dates